Eagle Pharmaceutical (NASDAQ: EGRX)
| Last Price | $57.12 |
| Net Change | $1.35 (2.42%) |
| Bid | $57.08 |
| Ask Price | $57.22 |
| Open Price | $56.01 |
| Previous Close Price | $55.77 |
| High Price | $58.37 |
| Low Price | $55.9 |
| Number of Trades | 1,148 |
| Volume | 160,794 |
| Fifty Two Week High | $97.15 (2017-05-10) |
| Fifty Two Week Low | $45.05 (2017-08-09) |
| Average Daily Volume | 360,029 |
| Share Outstanding | 15,170 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $0.52 (2017-08-09) |
| 2nd Quarter Earnings | $1.42 (2017-05-08) |
| 3nd Quarter Earnings | $3.52 (2017-03-01) |
| 4th Quarter Earnings | $0.73 (2016-11-09) |
| PE Ratio | $9.02 |
| EPS Growth | $-29.03 |
| Recent Earnings | $0.52 |
| Annual EPS | $6 |
| Last Quarter EPS | $ |
| Market Capitalization | $0.85B |
| Insider Shareholders % | 0.195% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 15,170 |
| Inst. Shareholder % | 0% |
| Annual Net Income | $0.1B |
| TTM Net Profit Margin | $39.32 |
| 1-Year Return | -8.27% |
| 3-Year Return | 330.66% |
| 5-Year Return | 334.68% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 0% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | -29.030001% |
| Dividends per Share | $ |
| Stock Split Ratio | |
| Beta | 1.31 |
EGRX News & Stock Updates
July 19, 2017
3 Biotech Stocks to Watch in 2017